Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Cytotherapy. 2015 Sep;17(9):1169–1177. doi: 10.1016/j.jcyt.2015.07.008

Characteristic Reference material Our cell type

Source Mixed cell population B-MSCs, A-MSCs etc

Cell surface markers CD13+, CD29+, CD31−, CD34−, CD44+, CD49e+, CD45−, CD73+, CD90+, CD105+, CD146+, CD166+, CD271−, c-Kit (CD117)−, Sca-1−, SSEA4+, Stro-1+, W8-B2/MSCA-1+, podXL+, CD49f+, CD11−, MHC I, MHC II, different types CD90+, CD105+, CD11 others not tested

Differentiation assays Osteo, adipo, chondro, IDO expression, Osteo+, Adipo+, others not tested

Gene expression assays A panel of over 1000 genes Tested 96 gene microarray kit for stem cell markers.

Secretome assays Cytokine panel and EV panel Cytokine panel shows TGFb+, IGF etc. EV panel not tested

Metabolite assays ATP/ADP, NAD/NADH, FAD/FADH ATP/ADP tested and others not tested

Freeze thaw assays The above phenotype before and after thaw Not tested